Found: 11
Select item for more details and to access through your institution.
The ribosome quality control factor Asc1 determines the fate of HSP70 mRNA on and off the ribosome.
- Published in:
- Nucleic Acids Research, 2023, v. 51, n. 12, p. 6370, doi. 10.1093/nar/gkad338
- By:
- Publication type:
- Article
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer.
- Published in:
- Nature Communications, 2016, v. 7, n. 12, p. 13665, doi. 10.1038/ncomms13665
- By:
- Publication type:
- Article
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04506-z
- By:
- Publication type:
- Article
An ‘in-cell trial’ to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxics.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 378, doi. 10.1016/j.molonc.2013.12.006
- By:
- Publication type:
- Article
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 324, p. 1, doi. 10.1126/scitranslmed.aad5640
- By:
- Publication type:
- Article
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 224, p. 1, doi. 10.1126/scitranslmed.3007947
- By:
- Publication type:
- Article
Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity.
- Published in:
- EMBO Reports, 2020, v. 21, n. 9, p. 1, doi. 10.15252/embr.202050446
- By:
- Publication type:
- Article
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 241, doi. 10.3390/cancers14010241
- By:
- Publication type:
- Article
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 685, doi. 10.3390/cancers12030685
- By:
- Publication type:
- Article
ROR1 is a pseudokinase that is crucial for METdriven tumorigenesis.
- Published in:
- BMC Proceedings, 2013, v. 7, n. Suppl 2, p. 1, doi. 10.1186/1753-6561-7-S2-P43
- By:
- Publication type:
- Article
The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 10, p. 2305, doi. 10.1002/ijc.28879
- By:
- Publication type:
- Article